| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 08/12/2009 | CN100526309C Dimeric compounds and their use as anti-viral agents |
| 08/12/2009 | CN100525823C Application of extractive of Daliangjiang, and application in medication |
| 08/12/2009 | CN100525817C Medicinal composition for treating tuberculosis and its preparing process |
| 08/12/2009 | CN100525800C Composition of Chinese traditional medicine for treating yellow / white flux of baby pig, and colibacillosis of birds |
| 08/12/2009 | CN100525773C Injectable azithromycin freeze-dried powder, and its preparation method |
| 08/12/2009 | CN100525768C Novel compounds |
| 08/12/2009 | CN100525749C Freeze-drying powder injection for treating calor febrilis and its production |
| 08/11/2009 | US7572900 Expression vector comprising breast cancer gene (BCL-2) nucleotide sequences for use as tool in treatment, diagnosis and prevention of cell proliferative disorders |
| 08/11/2009 | US7572890 Having activities to inhibit Hemagglutination by Influenza Viruses; lacks dihydrofolate reductase, possesses resistance to both neomycin and methotrexate |
| 08/11/2009 | US7572882 Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions |
| 08/11/2009 | US7572828 Identification of anti-HIV compounds inhibiting virus assembly and binding of nucleocapsid protein to nucleic acid |
| 08/11/2009 | US7572813 Cyclic amide derivative as monocyte chemotactic protein modulator; prevention and treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma; antiinflammatory agents; N-[2-[[(cis) -2-[[1- (4-Chlorophenyl)ethyl]amino]cyclohexyl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide |
| 08/11/2009 | US7572810 Alkene piperidine derivatives as antiviral agents |
| 08/11/2009 | US7572800 Administering anti-hepatitis B virus agents in combination or alternation such asbeta-2-hydroxymethyl-5-(5-fluorocytosin-1-yl-1,3-oxathiolane or a salt and one another antihepatitis B agent |
| 08/11/2009 | US7572773 Single dose fast dissolving azithromycin |
| 08/11/2009 | US7572466 Oral immunology using plant product containing a non-enteric pathogen antigen |
| 08/11/2009 | US7572449 Vaccine against Yersinia comprising one or two antibodies, one specific for Yersinia pestis F1-antigen and the other one for Yersinia pestis V-antigen |
| 08/11/2009 | US7572446 Antagonists of HMG1 for treating inflammatory conditions |
| 08/11/2009 | US7572442 Selected antibody compositions for binding to aminophospholipids |
| 08/11/2009 | US7572441 Media and method for treating pathological syndrome |
| 08/11/2009 | US7572438 Mutant having uracil phosphoribosyl transferase activity |
| 08/11/2009 | CA2564377C 6-o-substituted ketolides having antibacterial activity |
| 08/11/2009 | CA2546660C Selective inhibitors of viral or bacterial neuraminidase |
| 08/11/2009 | CA2448825C Pharmaceutical compositions of adsorbates of amorphous drug |
| 08/11/2009 | CA2410273C Halogenated rhodamine derivatives and applications thereof |
| 08/11/2009 | CA2408535C Compositions comprising dendrimer complexes |
| 08/11/2009 | CA2368688C Novel inhibitors of formation of advanced glycation endproducts (age's) |
| 08/11/2009 | CA2359772C Cyclic substituted fused pyrrolocarbazoles and isoindolones |
| 08/11/2009 | CA2287521C Human recombinant beta-interferon with improved solubility |
| 08/11/2009 | CA2271248C Use of a notch ligand in immunotherapy |
| 08/11/2009 | CA2222552C N-oxides as antibacterial agents |
| 08/11/2009 | CA2192940C Nucleotide sequences of pestivirus strains, polypeptides encoded by these sequences and use thereof for diagnosis and prevention of pestivirus infections |
| 08/08/2009 | CA2653300A1 Polyvalent vaccine against salmonid alphavirus infections |
| 08/06/2009 | WO2009096789A1 Composition for stimulating natural killer cell activity |
| 08/06/2009 | WO2009096772A1 Composition for stimulating natural killer cell activity |
| 08/06/2009 | WO2009096581A1 Membrane fusion inhibitor |
| 08/06/2009 | WO2009096503A1 Benzyl phenyl glucopyranoside derivative |
| 08/06/2009 | WO2009095993A1 Medicinal composition |
| 08/06/2009 | WO2009095796A2 Tapasin augmentation for enhanced immune response |
| 08/06/2009 | WO2009095634A1 Amorphous forms of retapamulin |
| 08/06/2009 | WO2009095588A2 Synthesis of novel neamine derivatives and use thereof as antibacterial agents |
| 08/06/2009 | WO2009095503A2 Amino acid derivatives used as pharmaceutical substances |
| 08/06/2009 | WO2009095499A1 Use of amidoxime carboxylic acid esters and n-hydroxyguanidine carboxylic acid esters for producing prodrugs |
| 08/06/2009 | WO2009095456A1 Peptide derivatives useful in the treatment, care or cleansing of the skin, mucosae, scalp or nails |
| 08/06/2009 | WO2009095387A1 Use of inhibitor of beta-lactamases and its combination with beta-lactam antibiotics |
| 08/06/2009 | WO2009094845A1 5-(3-heteroaromatic ring substituted phenyl) tetrazole compounds and their uses for anti-hiv/aids |
| 08/06/2009 | WO2009094807A1 Compounds from mycelium of antrodia cinnamomea and use thereof |
| 08/06/2009 | WO2009094798A1 A pharmaceutical product for filterable viral infection and processing method thereof |
| 08/06/2009 | WO2009094707A1 Antimicrobial surfaces |
| 08/06/2009 | WO2009048769A3 Vaccinia virus h3l and b5r specific monoclonal antibodies and methods of making and using same |
| 08/06/2009 | WO2009047791A3 Toll like receptor (tlr) signaling antagonist |
| 08/06/2009 | WO2009043522A3 Use of a peptide as a therapeutic agent |
| 08/06/2009 | WO2009043463A3 Use of gluten exorphin c : as a therapeutic agent |
| 08/06/2009 | WO2009033793A3 Pentagastrin as a therapeutic agent |
| 08/06/2009 | WO2009033721A3 Use of salusin beta alone or in combination with octreotide as a therapeutic agent |
| 08/06/2009 | WO2009024585A3 Imidazo [1,2-a] pyrazine compounds for treatment of viral infections such as hepatitis |
| 08/06/2009 | WO2009023179A3 Nitrogen containing bicyclic chemical entities for treating viral infections |
| 08/06/2009 | WO2008073961A8 Compounds and methods for modulating the silencing of a polynucleotide of interest |
| 08/06/2009 | US20090198063 Novel heterocyclic compound or salt thereof and intermediate thereof |
| 08/06/2009 | US20090197957 Methods and compositions for the treatment of pain |
| 08/06/2009 | US20090197946 Composition and method for treatment of inflamation and infections of the genitalia, contraceptive and the prophylaxis of sexually transmitted diseases |
| 08/06/2009 | US20090197910 Novel viral replication inhibitors |
| 08/06/2009 | US20090197888 Fluorinated tripeptide hcv serine protease inhibitors |
| 08/06/2009 | US20090197887 Piperazinylpiperidine derivatives as chemokine receptor antagonists |
| 08/06/2009 | US20090197880 Anti-viral compounds, compositions, and methods of use |
| 08/06/2009 | US20090197877 Antibacterial Compositions |
| 08/06/2009 | US20090197856 Antiviral compounds |
| 08/06/2009 | US20090197855 Pharmaceutical compositions of cefdinir |
| 08/06/2009 | US20090197848 Synthetic mimics of mammalian cell surface receptors: method and compositions |
| 08/06/2009 | US20090197827 Combination Therapy for Treatment of FIV Infection |
| 08/06/2009 | US20090197817 Tetrahdrofuro[3,2-B] pyrrol-3- one as cathepsin k inhibitors |
| 08/06/2009 | US20090197337 Methods for the production of multimeric proteins and related compositions |
| 08/06/2009 | US20090196945 Compositions and methods for treating bacteria |
| 08/06/2009 | US20090196887 Immunogenic Compositions for Activating Gamma Delta T Cells |
| 08/06/2009 | US20090196881 DNA vaccine against north american spring viremia of carp virus |
| 08/06/2009 | US20090196874 Anti-tsg101 antibodies and their uses for treatment of viral infections |
| 08/06/2009 | US20090196872 Human monoclonal antibodies to influenza m2 protein and methods of making and using same |
| 08/06/2009 | US20090196856 Method for Generating Dendritic Cells Employing Decreased Temperature |
| 08/06/2009 | US20090196853 Method of treating hepatitis virus infection with a multiphasic interferon delivery profile |
| 08/06/2009 | CA2713784A1 Use of amidoxime carboxylic acid esters and n-hydroxyguanidine carboxylic acid esters for producing prodrugs |
| 08/06/2009 | CA2713780A1 Amino acid derivatives used as pharmaceutical substances |
| 08/06/2009 | CA2712964A1 Tapasin augmentation for enhanced immune response |
| 08/06/2009 | CA2712283A1 Antimicrobial surfaces |
| 08/06/2009 | CA2711725A1 Synthesis of novel neamine derivatives and use thereof as antibacterial agents |
| 08/05/2009 | EP2085468A1 DNA transfection system for the generation of infectious influenza virus |
| 08/05/2009 | EP2085397A1 Crystalline form of abacavir |
| 08/05/2009 | EP2085394A2 Metronidazole derivatives as antiparasitic agents |
| 08/05/2009 | EP2085386A2 Pyridinium and quinolinium derivatives as Choline kinase inhibitors |
| 08/05/2009 | EP2085084A1 Use of inhibitor of beta-lactamases and its combination with beta-lactam antibiotics |
| 08/05/2009 | EP2084175A1 Hcv nucleoside inhibitor |
| 08/05/2009 | EP2084160A1 Hiv integrase inhibitors |
| 08/05/2009 | EP2083844A2 Hcv ns3 protease inhibitors |
| 08/05/2009 | EP2083839A2 Antiviral astragalus extract |
| 08/05/2009 | EP2083825A1 Compositions for the treatment of hepatitis c and methods for using compositions for the treatment of hepatitis c |
| 08/05/2009 | EP2083818A2 Melatonin derivatives and their use as antioxidants |
| 08/05/2009 | EP1789039A4 S-triazolyl alpha -mercaptoacetanildes as inhibitors of hiv reverse transcriptase |
| 08/05/2009 | EP1771178B1 Use of k-252a and kinase inhibitors for the prevention or treatment of hmgb1-associated pathologies |
| 08/05/2009 | EP1737821B1 3,4-(cyclopentyl)-fused proline compounds as inhibitors of hepatitis c virus ns3 serine protease |
| 08/05/2009 | EP1737459B1 Imidazopyridine and imidazopyrimidine derivatives as antibacterial agents |
| 08/05/2009 | EP1635799B1 Pharmaceutical formulations of amyloid inhibiting compounds |